Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Net Income towards Common Stockholders (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Net Income towards Common Stockholders for 10 consecutive years, with -$48.8 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders fell 9.42% to -$48.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$201.9 million through Dec 2025, up 23.67% year-over-year, with the annual reading at -$201.9 million for FY2025, 23.68% up from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was -$48.8 million at Rhythm Pharmaceuticals, up from -$54.3 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $43.8 million in Q1 2021, with the low at -$141.4 million in Q1 2024.
  • Average Net Income towards Common Stockholders over 5 years is -$45.5 million, with a median of -$44.9 million recorded in 2022.
  • The sharpest move saw Net Income towards Common Stockholders skyrocketed 228.06% in 2021, then crashed 220.07% in 2022.
  • Over 5 years, Net Income towards Common Stockholders stood at -$50.9 million in 2021, then rose by 16.44% to -$42.5 million in 2022, then grew by 2.02% to -$41.6 million in 2023, then decreased by 7.2% to -$44.6 million in 2024, then fell by 9.42% to -$48.8 million in 2025.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods came in at -$48.8 million, -$54.3 million, and -$48.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.